PlainRecalls
FDA Drug Moderate Class II Ongoing

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reported: October 8, 2025 Initiated: September 24, 2025 #D-0001-2026

Product Description

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reason for Recall

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Details

Units Affected
912 30-count bottles
Distribution
Distributed Nationwide in the USA
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 912 30-count bottles.
Why was this product recalled?
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
Which agency issued this recall?
This recall was issued by the FDA Drug on October 8, 2025. Severity: Moderate. Recall number: D-0001-2026.